Optoceutics ApS: Financial statements 2023
CVR: 39769689
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Optoceutics ApS (CVR 39769689) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 909,636 and a net result of DKK -7,211,522 compared with DKK -3,635,660 the year before. That is a decrease of 78.7% compared with the year before. Equity in the 2023 report amounted to DKK 28,914,208. The solvency ratio was 70.8%. The company had 14 employees in the financial year.
- Gross Profit
- DKK 909,636
- Profit/Loss
- DKK -7,211,522
- Equity
- DKK 28,914,208
- Total Assets
- DKK 40,815,608
- Employees
- 14
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 910 t. | -7.2 mio. | 28.9 mio. | 14 |
| 2022 | - | 4.3 mio. | -3.6 mio. | 16.9 mio. | 14 |
| 2021 | - | -2.2 mio. | -3.9 mio. | 13.4 mio. | 10 |
| 2020 | - | -132 t. | -506 t. | 16.2 mio. | 6 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 29, 2023, is registered as an owner of Optoceutics ApS with an ownership share of 5%.
As of November 8, 2023, David Lee Hardwick has joined the board of directors of Optoceutics ApS.
As of November 8, 2023, Rasmus Just has left the board of directors of Optoceutics ApS.
As of November 7, 2023, David Lee Hardwick has left the board of directors of Optoceutics ApS.
As of September 7, 2023, David Lee Hardwick has joined the board of directors of Optoceutics ApS.
Optoceutics ApS has published its annual report for 2022. Gross profit came to DKK 4,262,725, and the net result was DKK -3,635,660.
About Optoceutics ApS
Optoceutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Optoceutics IVS. The management consists of Ngoc Mai Thi Nguyen and Marcus Schultz Carstensen. The board consists of Jes Broeng (chair), Kaare Agerholm Danielsen, Marcus Schultz Carstensen and Ngoc Mai Thi Nguyen. The company's owners include Vjack Holding ApS, M. S. C. HOLDING ApS and Danielsen 2 ApS. According to the 2025 annual report, the company had an average of 7 employees. In 2025, the company reported a gross profit of DKK -2,585,556 and a net result of DKK -8,736,152 compared with DKK -9,184,625 the year before. Equity in the 2025 report amounted to DKK 32,320,160.